Welcome Cure
PrivateLast Round
Early Funding
Oct 19, 2023
Total Funding Raised
$6.5M
Company Overview
Welcome Cure is a healthtech company that provides an AI-powered integrative healthcare platform offering telemedicine, digital diagnostics, and traditional medical consultations.
Sector
Healthcare & Life Sciences
Verticals
Telemedicine, Medical AI, Patient Engagement, Vertical SaaS, Healthcare Analytics
Business Model
B2B
Customer Profile
Subscription SaaS, Services & Consulting, Usage-Based SaaS
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Welcome Cure Comparables
Compare Welcome Cure with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Pristyn Care | 78% | |
| DocOnline | 77% | |
| MediBuddy | 73% |
Welcome Cure Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Early Funding | Oct 19, 2023 | ||||
| Angel | Jul 20, 2018 | ||||
| Seed | Oct 7, 2015 |
Key People
Founding team and executive leadership
Welcome Cure Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Inflection Point Ventures | Early Funding |
| Brand Capital | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 12, 2026
Monthly visitors grew 72% MoM, reaching 32.8K.
- Jan 21, 2026
Monthly visitors increased 47% MoM.
Welcome Cure Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Welcome Cure's valuation, stock price, and market status.
Is Welcome Cure a public or private company?
Welcome Cure is a private company.
What is the current stock price of Welcome Cure?
Welcome Cure is a private company with no public stock price. Caplight tracks Welcome Cure's secondary market activity and provides MarketPrice™ estimates to Caplight users.
How much is Welcome Cure worth (valuation)?
Valuation information for Welcome Cure is not publicly available.
Can I buy Welcome Cure stock?
Welcome Cure shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Welcome Cure's last funding round?
Welcome Cure's most recent funding round was Early Funding on October 19, 2023.
Who are the main investors in Welcome Cure?
Key investors in Welcome Cure include Inflection Point Ventures, Brand Capital.
Will Welcome Cure IPO soon?
No public IPO plans have been announced for Welcome Cure.
How can I track Welcome Cure secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Welcome Cure's secondary market activity and sign up for updates.